<DOC>
	<DOCNO>NCT01677845</DOCNO>
	<brief_summary>The aim study determine maximum tolerate dose hypo-fractionated radiation therapy toxicity treatment program . Eligible patient stage T1-2c prostate cancer sign consent enrol phase I dose escalation trial treat hypo-fractionated radiation therapy ( HRT ) . Dose escalation follow : There 3 cohort consist 3 patient .</brief_summary>
	<brief_title>Hypo-Fractionated Radiation Therapy Localized Prostate Cancer</brief_title>
	<detailed_description>Dose escalation follow : There 3 cohort consist 3 patient . All patient receive 18 fraction HRT course 6 week ( 3 fraction per week ) . Dose level I 54Gy ( 3 Gy per fraction ) , dose level II 55.8 Gy ( 3.1Gy per fraction ) , dose level III 57.6 Gy ( 3.2 Gy per fraction ) . After accrual dose level I , patient observe minimum two week completion radiation treatment , assessment toxicity , dose escalate next cohort . After dose level II , patient observe 6 month enrol patient dose level III . All patient see weekly radiation oncologist radiation therapy . Any observation regard radiation reaction record .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>History/physical examination digital rectal examination prostate within 8 week prior registration Clinical stage T12c ( AJCC 6th edition ) Gleason &lt; 6 PSA &lt; 10 ng/mL Gleason =7 and/or PSA 1020 ng/mL provide &lt; 34 % core biopsy positive carcinoma PSA &lt; 20 ng/mL within 180 day prior registration . PSA obtain least 10 day prostate biopsy . Zubrod performance status 01 Age â‰¥ 18 Patient must sign study specific informed consent prior randomization . Prior concurrent invasive malignancy ( except nonmelanomatous skin cancer ) lymphomatous/hematogenous malignancy unless continually disease free minimum 5 year . ( For example , carcinoma situ bladder oral cavity permissible ) Evidence distant metastasis Regional lymph node involvement Previous radical surgery ( prostatectomy ) cryosurgery prostate cancer Prior androgen deprivation therapy ( ADT ) Previous pelvic irradiation , prostate brachytherapy , bilateral orchiectomy Previous concurrent cytotoxic chemotherapy prostate cancer</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Localized Prostate Cancer</keyword>
	<keyword>Radiation</keyword>
</DOC>